Both in Biotechnology
Tectonic Therapeutic vs C4 Therapeutics
Over the past year TECX returned +21.3% and CCCC returned +38.1%; their daily moves had a correlation of 0.22.
TECX +21.3% CCCC +38.1%Growth of $1, one year, split-adjusted
| Metric | TECX | CCCC |
|---|---|---|
| Price | $20.30 | $3.12 |
| Market cap | $396.9M | $383.8M |
| Today | +6.95% | −2.80% |
| 1 month | −9.4% | +8.3% |
| 6 months | −30.0% | +6.5% |
| Year to date | −2.7% | +63.4% |
| 1 year | +15.9% | +25.8% |
| Revenue growth (YoY) | — | +2.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −355.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 11.0× |
| Net cash | $226.9M | $253.7M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 64.0% |
| Short % of float | 19.1% | 43.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).